Learn More
Medchemexpress LLC 2-hydroxy-3-[(1R)-1-(4-isopropyl-2-furyl)propylamino-cyclobutenylamino]-N,N-dimethylbenzamide | 473728-58-4 | 99.9% | 425.48 g·mol-1 | C23H27N3O5 | 100 MG

Supplier: Medchemexpress LLC HY10011100MG
SCH 563705 is a potent, orally active small-molecule antagonist of the CXC chemokine receptors CXCR2 and CXCR1 used as a research compound to probe receptor signaling in inflammation and oncology. It demonstrates low-nanomolar receptor potency and is supplied as a high-purity solid suitable for in vitro and preclinical in vivo studies.
- Dual CXCR1/CXCR2 antagonism providing broad chemokine receptor coverage.
- Low-nanomolar potency (CXCR2 IC50 = 1.3 nM; CXCR1 IC50 = 7.3 nM).
- High chemical purity for reliable experimental results.
- Solid form suitable for formulation and dosing in preclinical studies.
- Characterized by CAS number and molecular weight for accurate identification.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.